Sentence examples for deterioration in the rate of from inspiring English sources

Meanwhile, James Heckman has pointed out that the slowdown in growth of college graduation rates is directly related to deterioration in the rate of high school graduation, which also suggests that better preparation before college attendance is needed.

Here we note that X 0, div h in Corollary 2 can be quite restrictive, yielding deterioration in the rate of convergence.

Two damage indexes, i.e., the concrete strength deterioration rate and the rate of change in ultrasonic velocity of concrete, were carefully defined to quantitatively characterize the mechanical damage to the concrete due to sulfate attack.

These SNPs were consequently used for genotyping of seven F2 families with individuals that showed differences in the rate of deterioration.

In the future, we will analyze other lettuce populations, determine the existence of additional QTLs involved in the rate of deterioration, and study the stability of this trait when plants from different environments are processed for salad.

Currently, the patient remains in remission, with proteinuria reduced to 1.55 g/24 h, 4 years after treatment, with a slowing in the rate of deterioration of his renal function (eGFR 23 mL/min).

Further, high-dose vitamin E as an add-on therapy to riluzole in ALS did not extend survival, although improvement in the rate of deterioration of function was suggested for vitamin E. 97 Another group of antioxidants associated with a lower risk of ALS is polyunsaturated fatty acids, 92, 98, 99 which may modulate lipid metabolism, oxidative stress, and inflammatory processes.

Interestingly, there appeared to be no overall difference between the two groups in the risk of developing, or age of development of, CKD3 or CKD4, or in the rate of functional deterioration (eGFR) once CKD had supervened.

The cut-off points for the tails in the rate of glycaemic deterioration are determined using data from the sequential HbA1c data collected during the 18-month follow-up period.

However, because the predicted clinical effect of this type of disease-modifying drugs is a less-pronounced slope in the rate of cognitive deterioration, without any early symptomatologic effect, very large clinical trials with extended treatment periods will be needed to identify a beneficial clinical effect by using rating scales.

In addition, studies in which the rate of deterioration in the placebo group was extrapolated and compared with the level of function of patients continuing treatment with a ChEI suggest that patients continue to derive modest benefit from treatment for two to three years (Rogers et al 2000).